MedTrace Logo

Evaluation of Conservative Management of Teeth With Deep Cavitated Carious Lesions

NCT06171776 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-12-15

No results posted yet for this study

Summary

The goal of this clinical trial is to compare postoperative pain of calcium silicate cement and resin-based tricalcium silicate (TheraCal LC) versus chemically Cured Glass Ionomer cement (FujiXI) in conservative management of very deep carious lesions by selective caries removal

Conditions

  • Deep Caries
  • Pulp Exposure, Dental

Interventions

DRUG

RetroMTA

calcium silicate lining material work as dentin substitute

DRUG

TheraCal

calcium silicat material light cured

DRUG

Fuji IX

filling material bonded chemically to the tooth structure

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-01-01
Completion
2025-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06171776 on ClinicalTrials.gov